José Carlos Segovia Sanz-rekin lankidetzan egindako argitalpenak (4)

2024

  1. Restored glyoxylate metabolism after AGXT gene correction and direct reprogramming of primary hyperoxaluria type 1 fibroblasts

    iScience, Vol. 27, Núm. 4

2023

  1. A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features

    Blood, Vol. 142, Núm. 20, pp. 1752-1756

  2. Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL

    British Journal of Haematology

2020

  1. In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells

    Nature Communications, Vol. 11, Núm. 1